Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.
Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.
安進股票交易走低，受到其與MariTide合作在肥胖症的2期研究結果影響。
Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.
安進的股票在其與MariTide針對肥胖的二期研究結果公佈後，交易價格下跌。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間